221 related articles for article (PubMed ID: 38416279)
1. Herpes Zoster Recurrence: A Narrative Review of the Literature.
Parikh R; Spence O; Giannelos N; Kaan I
Dermatol Ther (Heidelb); 2024 Mar; 14(3):569-592. PubMed ID: 38416279
[TBL] [Abstract][Full Text] [Related]
2. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention.
Litt J; Cunningham AL; Arnalich-Montiel F; Parikh R
Infect Dis Ther; 2024 Jul; 13(7):1439-1459. PubMed ID: 38834857
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Burden of Herpes Zoster in Sweden: A Regional Population-Based Register Study.
Södergren E; Mårdberg K; Nishimwe M; Bhavsar A; Marijam A; Bergström T; Stäck P
Infect Dis Ther; 2024 Jan; 13(1):121-140. PubMed ID: 38193987
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Safonova E; Yawn BP; Welte T; Wang C
Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298
[TBL] [Abstract][Full Text] [Related]
5. [Reactivation of herpes zoster infection by varicella-zoster virus].
Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
[TBL] [Abstract][Full Text] [Related]
6. A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.
Chen J; Abrahamson PE; Ke Y; Ong CR; Parikh R; Shantakumar S
Hum Vaccin Immunother; 2024 Dec; 20(1):2344983. PubMed ID: 38767209
[TBL] [Abstract][Full Text] [Related]
7. Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
Mwakingwe-Omari A; Lecrenier N; Naficy A; Curran D; Posiuniene I
Hum Vaccin Immunother; 2023 Dec; 19(3):2278362. PubMed ID: 37965770
[TBL] [Abstract][Full Text] [Related]
8. Public health impact of herpes zoster vaccination on older adults in Hong Kong.
Chan PKS; Wong MCS; Chan M; Ching K; Giannelos N; Ng C
Hum Vaccin Immunother; 2023 Dec; 19(1):2176065. PubMed ID: 36854447
[TBL] [Abstract][Full Text] [Related]
9. A systematic literature review to assess the burden of herpes zoster disease in China.
Yin D; Van Oorschot D; Jiang N; Marijam A; Saha D; Wu Z; Tang H; Diaz-Decaro J; Watson P; Xie X; Ren Y; He Y; Feng Y
Expert Rev Anti Infect Ther; 2021 Feb; 19(2):165-179. PubMed ID: 32997550
[TBL] [Abstract][Full Text] [Related]
10. Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007-2018.
Batram M; Witte J; Schwarz M; Hain J; Ultsch B; Steinmann M; Bhavsar A; Wutzler P; Criée CP; Hermann C; Wahle K; Füchtenbusch M; Greiner W
Dermatol Ther (Heidelb); 2021 Jun; 11(3):1009-1026. PubMed ID: 33959878
[TBL] [Abstract][Full Text] [Related]
11. Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.
Oh H; Tan C; Williams C; Giannelos N; Ng C
Hum Vaccin Immunother; 2024 Dec; 20(1):2348839. PubMed ID: 38804600
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster in Belgium: a new solution to an old problem.
Nikkels AF; Schoevaerdts D; Kauffmann F; Strubbe F; Bensemmane S
Acta Clin Belg; 2024 May; ():1-12. PubMed ID: 38781037
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
Liesegang TJ
Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
[TBL] [Abstract][Full Text] [Related]
14. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
[TBL] [Abstract][Full Text] [Related]
15. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Parikh R; Widenmaier R; Lecrenier N
Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
18. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
20. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
